-
PROVIDERS
FEATURED ARTICLE
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
LIVE WEBINAR
Precision pathways: Insights and strategies to navigate regulatory requirements for oncology diagnostics
Thursday, October 17
12:00pm CT -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
CARE PATHWAY intelligence SOLUTIONs
Tempus Next
An AI-enabled care pathway platform that enables providers to deliver the Next step in a patient’s care journey.
Improve adherence to clinical guidelines through AI-enabled and targeted notifications at the point of care.
Our Solution
Tempus Next: AI-enabled care pathway intelligence
Tempus Next applies technology, data, and AI to enable precision medicine, empowering providers to deliver the next step in a patient’s care journey and foster value based care within health systems.
Identify and contextualize patients in their care journey
AI-enabled solutions designed to surface deep insights from multimodal, longitudinal patient data including medical imaging data, EHR data, lab results, pathology reports and clinician notes.
Surface precision care pathways at the point of care
Tiered and customized notifications consistent with precision medicine guidelines in the physician’s workflow reduce alert fatigue.
Track patients for timely follow-up to help improve outcomes
Patient Tracking for patients with current disease who need management, Patient Lists to search for subsets of patients and Dashboards to track insights into a hospital’s patient population.
Monitor notification effectiveness and guidelines adoption
Institution-level insights reports delivered to hospital systems help understand effectiveness of the notifications, emerging trends in guideline adoption, and patient outcomes.
Increase equitable access to care
Tempus is committed to the mission of providing timely and accurate diagnostics, procedures and therapies for all patients, regardless of socioeconomic status.
Figure: In this study, black patients saw a larger decrease in average time from index echo to follow up (120 vs 64 days) compared to white patients (57 to 36 days), showing the improvement in black patients’ time to follow up towards the average seen in white patients’ (narrowing the gap).
Horde G, Sotelo M, D’Amico A, et al. Use of an echocardiographic-based, artificial intelligence system to improve racial disparities in care of patients with valvular heart disease. European Heart Journal – Cardiovascular Imaging. 2023;24(Suppl 1):38.3.
Using AI to Identify and Close Gaps in Care for Cancer Patients
Learn how TriHealth Cancer and Blood Institute implemented Tempus Next to accelerate the adoption of precision care pathways for NSCLC patients.
Watch our webinarCase Study
Closing the biomarker testing gap for early stage NSCLC patients with Tempus NextLearn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
LEARN MORE
Tempus Next for Oncology
-
Reduce undertesting of biomarkers associated with immunotherapy eligibility (PDL1, MSI, TMB)
-
Identify patients with actionable alterations to consider for FDA approved targeted therapies consistent with clinical guidelines
-
Help prevent chemotherapy toxicity in patients with identifiable pharmacogenomic alterations
Learn more about Tempus Next
Chris Scotto DiVetta, SVP of Applications at Tempus AI introduces Tempus Next, an AI enabled care pathway platform that helps providers accelerate the adoption of evidence based care.
Watch replayThis is data-driven precision medicine
This is the future of healthcare.